Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

IART – Integra LifeSciences Holdings Corporation

Float Short %

11.19

Margin Of Safety %

Put/Call OI Ratio

0.13

EPS Next Q Diff

-0.06

EPS Last/This Y

2.29

EPS This/Next Y

0.15

Price

12.17

Target Price

15.5

Analyst Recom

3.09

Performance Q

-23.24

Relative Volume

0.51

Beta

1.04

Ticker: IART




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-26IART12.640.090.00569
2025-12-29IART12.60.09999.99568
2025-12-30IART12.690.09999.99568
2025-12-31IART12.410.080.33564
2026-01-02IART12.020.090.00568
2026-01-05IART12.570.090.00568
2026-01-06IART13.120.090.08573
2026-01-07IART13.150.090.08573
2026-01-08IART13.880.080.14600
2026-01-09IART13.580.100.57666
2026-01-12IART13.140.10999.99675
2026-01-13IART12.350.10999.99675
2026-01-14IART12.530.102.50696
2026-01-15IART12.670.110.00709
2026-01-16IART12.40.110.00710
2026-01-20IART120.120.00606
2026-01-21IART12.190.12999.99609
2026-01-22IART12.190.1315.00611
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




18 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-26IART12.61-17.5- 2.20
2025-12-29IART12.61-17.5- 2.20
2025-12-30IART12.70-17.5- 2.20
2025-12-31IART12.41-17.5- 2.20
2026-01-02IART12.02-17.5- 2.20
2026-01-05IART12.57-17.5- 2.20
2026-01-06IART13.12-17.5- 2.20
2026-01-07IART13.15-17.5- 2.20
2026-01-08IART13.88-17.5- 2.20
2026-01-09IART13.57-17.5- 2.20
2026-01-12IART13.15-17.5- 2.20
2026-01-13IART12.34-17.5- 2.20
2026-01-14IART12.52-17.5- 2.20
2026-01-15IART12.64-17.5- 2.20
2026-01-16IART12.39-17.5- 2.20
2026-01-20IART12.00-17.5- 2.20
2026-01-21IART12.19-17.5- 2.20
2026-01-22IART12.17-17.5- 2.20
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
18 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-26IART0.07-0.7210.45
2025-12-29IART0.07-0.7210.45
2025-12-30IART0.07-0.7210.45
2025-12-31IART0.07-0.7210.45
2026-01-02IART0.07-0.7210.45
2026-01-05IART0.07-0.7210.45
2026-01-06IART0.07-0.7210.45
2026-01-07IART0.07-0.7210.45
2026-01-08IART0.07-0.7210.45
2026-01-09IART0.07-0.7210.45
2026-01-12IART0.07-0.7310.45
2026-01-13IART0.07-0.7311.19
2026-01-14IART0.07-0.7311.19
2026-01-15IART0.07-0.7311.19
2026-01-16IART0.07-0.7311.19
2026-01-20IART0.070.7811.19
2026-01-21IART0.070.7811.19
2026-01-22IART0.070.7811.19
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

0.54

Avg. EPS Est. Current Quarter

0.8

Avg. EPS Est. Next Quarter

0.48

Insider Transactions

0.07

Institutional Transactions

0.78

Beta

1.04

Average Sales Estimate Current Quarter

429

Average Sales Estimate Next Quarter

392

Fair Value

Quality Score

36

Growth Score

35

Sentiment Score

2

Actual DrawDown %

84.3

Max Drawdown 5-Year %

-85.6

Target Price

15.5

P/E

Forward P/E

5.19

PEG

6.03

P/S

0.58

P/B

0.91

P/Free Cash Flow

EPS

-6.46

Average EPS Est. Cur. Y​

2.2

EPS Next Y. (Est.)

2.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-30.15

Relative Volume

0.51

Return on Equity vs Sector %

-75

Return on Equity vs Industry %

-65.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Integra LifeSciences Holdings C
Sector: Healthcare
Industry: Medical Devices
Employees: 4396
Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
stock quote shares IART – Integra LifeSciences Holdings Corporation Stock Price stock today
news today IART – Integra LifeSciences Holdings Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch IART – Integra LifeSciences Holdings Corporation yahoo finance google finance
stock history IART – Integra LifeSciences Holdings Corporation invest stock market
stock prices IART premarket after hours
ticker IART fair value insiders trading